Improved Detection of Target Metabolites in Brain Tumors with Intermediate TE, High SNR, and High Bandwidth Spin-Echo Sequence at 5T

References

1. 1.↵
   2. Mack SC,
   3. Hubert CG,
   4. Miller TE, et al

   . An epigenetic gateway to brain tumor cell identity. Nat Neurosci 2016;19:10–19 doi:10.1038/nn.4190 pmid:26713744

   CrossRefPubMed
2. 2.↵
   2. Di Bonaventura R,
   3. Montano N,
   4. Giordano M, et al

   . Reassessing the role of brain tumor biopsy in the era of advanced surgical, molecular, and imaging techniques-a single-center experience with long-term follow-up. J Pers Med 2021;11:909 doi:10.3390/jpm11090909 pmid:34575685

   CrossRefPubMed
3. 3.↵
   2. Haubold J,
   3. Demircioglu A,
   4. Gratz M, et al

   . Non-invasive tumor decoding and phenotyping of cerebral gliomas utilizing multiparametric 18F-FET PET-MRI and MR fingerprinting. Eur J Nucl Med Mol Imaging 2020;47:1435–45 doi:10.1007/s00259-019-04602-2 pmid:31811342

   CrossRefPubMed
4. 4.↵
   2. Bednarik P,
   3. Goranovic D,
   4. Svatkova A, et al

   .¹H magnetic resonance spectroscopic imaging of deuterated glucose and of neurotransmitter metabolism at 7 T in the human brain. Nat Biomed Eng 2023;7:1001–13 doi:10.1038/s41551-023-01035-z pmid:37106154

   CrossRefPubMed
5. 5.↵
   2. Wang Q,
   3. Zhang H,
   4. Zhang J, et al

   . The diagnostic performance of magnetic resonance spectroscopy in differentiating high-from low-grade gliomas: a systematic review and meta-analysis. Eur Radiol 2016;26:2670–84 doi:10.1007/s00330-015-4046-z pmid:26471274

   CrossRefPubMed
6. 6.↵
   2. Gatenby RA,
   3. Gillies RJ

   . Why do cancers have high aerobic glycolysis? Nat Rev Cancer 2004;4:891–99 doi:10.1038/nrc1478 pmid:15516961

   CrossRefPubMedWeb of Science
7. 7.↵
   2. Griffin JL,
   3. Kauppinen RA

   . A metabolomics perspective of human brain tumours. FEBS J 2007;274:1132–39 doi:10.1111/j.1742-4658.2007.05676.x pmid:17298437

   CrossRefPubMed
8. 8.↵
   2. Krishnamoorthy T,
   3. Radhakrishnan VV,
   4. Thomas B, et al

   . Alanine peak in central neurocytomas on proton MR spectroscopy. Neuroradiology 2007;49:551–54 doi:10.1007/s00234-007-0224-2 pmid:17364196

   CrossRefPubMed
9. 9.↵
   2. Maudsley AA,
   3. Andronesi OC,
   4. Barker PB, et al

   . Advanced magnetic resonance spectroscopic neuroimaging: experts' consensus recommendations. NMR Biomed 2021;34:e4309 doi:10.1002/nbm.4309 pmid:32350978

   CrossRefPubMed
10. 10.↵
    2. Kim JH,
    3. Chang KH,
    4. Na DG, et al

    . Comparison of 1.5T and 3T 1H MR spectroscopy for human brain tumors. Korean J Radiol 2006;7:156–61 doi:10.3348/kjr.2006.7.3.156 pmid:16969044

    CrossRefPubMed
11. 11.↵
    2. Sjøbakk TE,
    3. Lundgren S,
    4. Kristoffersen A, et al

    . Clinical ¹H magnetic resonance spectroscopy of brain metastases at 1.5T and 3T. Acta Radiol 2006;47:501–08 doi:10.1080/02841850600644808 pmid:16796315

    CrossRefPubMed
12. 12.↵
    2. McCarthy L,
    3. Verma G,
    4. Hangel G, et al

    . Application of 7T MRS to high-grade gliomas. AJNR Am J Neuroradiol 2022;43:1378–95 doi:10.3174/ajnr.A7502 pmid:35618424

    Abstract/FREE Full Text
13. 13.↵
    2. Berrington A,
    3. Voets NL,
    4. Larkin SJ, et al

    . A comparison of 2-hydroxyglutarate detection at 3 and 7 T with long-TE semi-LASER. NMR Biomed 2018;31 doi:10.1002/nbm.3886 pmid:29315915

    CrossRefPubMed
14. 14.↵
    2. Wilson M,
    3. Andronesi O,
    4. Barker PB, et al

    . Methodological consensus on clinical proton MRS of the brain: review and recommendations. Magn Reson Med 2019;82:527–50 doi:10.1002/mrm.27742 pmid:30919510

    CrossRefPubMed
15. 15.↵
    2. Henning A

    . Proton and multinuclear magnetic resonance spectroscopy in the human brain at ultra-high field strength: a review. Neuroimage 2018;168:181–98 doi:10.1016/j.neuroimage.2017.07.017 pmid:28712992

    CrossRefPubMed
16. 16.↵
    2. Bingölbali A,
    3. Fallone BG,
    4. Yahya A

    . Comparison of optimized long echo time STEAM and PRESS proton MR spectroscopy of lipid olefinic protons at 3 Tesla. J Magn Reson Imaging 2015;41:481–86 doi:10.1002/jmri.24532 pmid:24338999

    CrossRefPubMed
17. 17.↵
    2. Fernandes CC,
    3. Lanz B,
    4. Chen C, et al

    . Measurement of brain lactate during visual stimulation using a long TE semi-LASER sequence at 7 T. NMR Biomed 2020;33:e4223 doi:10.1002/nbm.4223 pmid:31995265

    CrossRefPubMed
18. 18.↵
    2. Penner J,
    3. Bartha R

    . Semi-LASER ¹H MR spectroscopy at 7 Tesla in human brain: metabolite quantification incorporating subject-specific macromolecule removal. Magn Reson Med 2015;74:4–12 doi:10.1002/mrm.25380 pmid:25081993

    CrossRefPubMed
19. 19.↵
    2. Wong D,
    3. Schranz AL,
    4. Bartha R

    . Optimized in vivo brain glutamate measurement using long-echo-time semi-LASER at 7 T. NMR Biomed 2018;31:e4002 doi:10.1002/nbm.4002 pmid:30144183

    CrossRefPubMed
20. 20.↵
    2. Prener M,
    3. Opheim G,
    4. Shams Z, et al

    . Single-voxel MR spectroscopy of gliomas with s-LASER at 7T. Diagnostics (Basel) 2023;13:1805 doi:10.3390/diagnostics13101805

    CrossRefPubMed
21. 21.↵
    2. Jones SE,
    3. Lee J,
    4. Law M

    . Neuroimaging at 3T vs 7T: is it really worth it? Magn Reson Imaging Clin N Am 2021;29:1–12 doi:10.1016/j.mric.2020.09.001 pmid:33237010

    CrossRefPubMed
22. 22.↵
    2. Shi Z,
    3. Zhao X,
    4. Zhu S, et al

    . Time-of-flight intracranial MRA at 3 T versus 5 T versus 7 T: visualization of distal small cerebral arteries. Radiology 2022;305:E72 doi:10.1148/radiol.229027 pmid:36409618

    CrossRefPubMed
23. 23.↵
    2. Wei Z,
    3. Chen Q,
    4. Han S, et al

    . 5T magnetic resonance imaging: radio frequency hardware and initial brain imaging. Quant Imaging Med Surg 2023;13:3222–40 doi:10.21037/qims-22-945 pmid:37179946

    CrossRefPubMed
24. 24.↵
    2. Liu Y,
    3. Wang W,
    4. Zheng Y, et al

    . Magnetic resonance T1ρ quantification of human brain at 5.0 T: a pilot study. Front Phys 2022;10:1016932 doi:10.3389/fphy.2022.1016932

    CrossRef
25. 25.↵
    2. Jiang Z,
    3. Sun W,
    4. Xu D, et al

    . Stability and repeatability of diffusion-weighted imaging (DWI) of normal pancreas on 5.0 Tesla magnetic resonance imaging (MRI). Sci Rep 2023;13:11954 doi:10.1038/s41598-023-38360-x pmid:37488151

    CrossRefPubMed
26. 26.↵
    2. Zheng L,
    3. Yang C,
    4. Liang L, et al

    . T2-weighted MRI and reduced-FOV diffusion-weighted imaging of the human pancreas at 5 T: a comparison study with 3 T. Med Phys 2023;50:344–53 doi:10.1002/mp.15970 pmid:36107133

    CrossRefPubMed
27. 27.↵
    2. Zheng L,
    3. Yang C,
    4. Sheng R

    , et al. Renal imaging at 5 T versus 3 T: a comparison study. Insights Imaging 2022;13:155 doi:10.1186/s13244-022-01290-9 pmid:36153471

    CrossRefPubMed
28. 28.↵
    2. Zhang Y,
    3. Yang C,
    4. Liang L, et al

    . Preliminary experience of 5.0 T higher field abdominal diffusion-weighted MRI: agreement of apparent diffusion coefficient with 3.0 T imaging. J Magn Reson Imaging 2022;56:1009–17 doi:10.1002/jmri.28097 pmid:35119776

    CrossRefPubMed
29. 29.↵
    2. Kraff O,
    3. Quick HH

    . 7T: physics, safety, and potential clinical applications. J Magn Reson Imaging 2017;46:1573–89 doi:10.1002/jmri.25723 pmid:28370675

    CrossRefPubMed
30. 30.↵
    2. Scheenen TW,
    3. Klomp DW,
    4. Wijnen JP, et al

    . Short echo time 1H-MRSI of the human brain at 3T with minimal chemical shift displacement errors using adiabatic refocusing pulses. Magn Reson Med 2008;59:1–6 doi:10.1002/mrm.21302 pmid:17969076

    CrossRefPubMed
31. 31.↵
    2. Dacko M,
    3. Lange T

    . Improved detection of lactate and β-hydroxybutyrate using MEGA-sLASER at 3 T. NMR Biomed 2019;32:e4100 doi:10.1002/nbm.4100 pmid:31038254

    CrossRefPubMed
32. 32.↵
    2. Fuchs A,
    3. Luttje M,
    4. Boesiger P, et al

    . SPECIAL semi-LASER with lipid artifact compensation for 1H MRS at 7 T. Magn Reson Med 2013;69:603–12 doi:10.1002/mrm.24292 pmid:22517487

    CrossRefPubMed
33. 33.↵
    2. Ganji SK,
    3. An Z,
    4. Tiwari V, et al

    . In vivo detection of 2-hydroxyglutarate in brain tumors by optimized point-resolved spectroscopy (PRESS) at 7T. Magn Reson Med 2017;77:936–44 doi:10.1002/mrm.26190 pmid:26991680

    CrossRefPubMed
34. 34.↵
    2. Shams Z,
    3. van der Kemp WJ,
    4. Emir U, et al

    . Comparison of 2-hydroxyglutarate detection with sLASER and MEGA-sLASER at 7T. Front Neurol 2021;12:718423 doi:10.3389/fneur.2021.718423 pmid:34557149

    CrossRefPubMed
35. 35.↵
    2. Enoki T,
    3. Jomoto W,
    4. Yamano T, et al

    . Influences of tumor volume and FWHM of the water peak and T2* value of water on the detection rate of the choline peaks in proton MR spectroscopy of breast cancer at 3.0 T-MRI [in Japanese]. Nihon Hoshasen Gijutsu Gakkai Zasshi 2021;77:351–57 doi:10.6009/jjrt.2021_JSRT_77.4.351 pmid:33883369

    CrossRefPubMed
36. 36.↵
    2. Li X,
    3. Yang Y,
    4. Zhang B, et al

    . Lactate metabolism in human health and disease. Signal Transduct Target Ther 2022;7:305 doi:10.1038/s41392-022-01151-3 pmid:36050306

    CrossRefPubMed
37. 37.↵
    2. Ijare O,
    3. Baskin D,
    4. Pichumani K

    . CBMT-01: alanine fuels energy metabolism of glioblastoma cells. Neuro Oncol 2019;21:vi32–33 doi:10.1093/neuonc/noz175.123

    CrossRef